E independently by the investigators. All information analyses had been performed independently

E independently by the investigators. All information analyses had been performed independently by statisticians from the Duke Clinical Study Institute (Durham, NC), using an independent copy in the database.DisclosuresCornel reports receiving consulting payments from Eli Lilly, Merck Sharp and Dohme, AstraZeneca, and Merck. Ohman reports getting grant support and travel expenses from Daiichi Sankyo and Eli Lilly; consulting charges from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Liposcience, Merck, Pozen, Hoffmann-La Roche, Sanofi-Aventis, The Medicines Company, andDOI: ten.1161/JAHA.116.Net MD; grant support from Gilead Sciences; and lecture charges from Gilead Sciences, Boehringer Ingelheim, and the Medicines Firm. Jakubowski is an employee and minor shareholder of Eli Lilly and Business. Bhatt discloses the following relationships: Advisory board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; board of directors: Boston VA Investigation Institute, Society of Cardiovascular Patient Care; chair: American Heart Association Get Using the Suggestions Steering Committee; information monitoring committees: Duke Clinical Investigation Institute, Harvard Clinical Study Institute, Mayo Clinic, Population Well being Analysis Institute; honoraria: American College of Cardiology (senior associate editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor in chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor in chief, Journal of Invasive Cardiology), Journal with the American College of Cardiology (associate editor), Population Well being Investigation Institute (clinical trial steering committee), Slack Publications (chief healthcare editor, Cardiology Today’s Intervention), and WebMD (CME steering committees); other: Clinical Cardiology (deputy editor); study funding: Amarin, AstraZeneca, Biotronik, BristolMyers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi Aventis, St.IL-17A Protein web Jude Healthcare, plus the Medicines Organization; trustee: American College of Cardiology; and unfunded research: FlowCo, PLx Pharma, and Takeda.PRDX5/Peroxiredoxin-5 Protein Gene ID White reports receiving grant help from SanofiAventis, Eli Lilly, The Medicines Enterprise, NIH, Pfizer, Roche, Johnson Johnson, Schering-Plough, Merck Sharp Dohme, AstraZeneca, GlaxoSmithKline, Daiichi Sankyo Pharma Development, and Bristol-Myers Squibb; he also participates in advisory boards for Merck Sharpe Dohme, Roche, and Regado Biosciences.PMID:23075432 Ardissino reports getting consulting payments from Eli Lilly. Fox reports getting investigation grants from Lilly, Bayer, Johnson Johnson, and AstraZeneca; speakers bureau payments from Bayer, Johnson Johnson, AstraZeneca, and Sanofi-Aventis; and consulting/other payments from Lilly, Bayer, Johnson Johnson, AstraZeneca, Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly. Prabhakaran reports receiving investigation grants from Eli Lilly along with the Medtronic Foundation and honoraria from Eli Lilly. Armstrong reports receiving consulting costs from Eli Lilly, Hoffmann-La Roche, Merck, Axio Analysis, and Orexigen; grant support from Boehringer Ingelheim, Hoffmann-La Roche, Sanofi-Aventis, Scios, Ortho Biotech, Johnson Johnson, Janssen Pharmaceuticals, GlaxoSmithKline, Amylin Pharmaceuticals, and Merck; and payment for developing educatio.